Author

Christopher Bruhn

Evotec (Germany)ORCID 0000-0001-6656-996XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Alexandra Hackmann· 1 shared Alice DrobnyiD· 1 shared Bastian ZimmeriD· 1 shared Carina WollnikiD· 1 shared Carsten Jörn BeeseiD· 1 shared Fabrizia Zoppetti· 1 shared Henrik RenneriD· 1 shared Kinga Maria WronaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alexandra Hackmann

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintOct 30, 2026

✦ In-depth digest

A human induced pluripotent stem cell-based high-throughput screening platform for teratogenicity hazard identification

Henrik Renner, Kinga Maria Wrona, Christopher Bruhn…·Bastian Zimmer

Four-model hiPSC screen in 384-well imaging reached 83% accuracy (88% sensitivity, 75% specificity) on 130 scored compounds from a 146-compound reference set, scalable to hundreds of compounds monthly.

DOI 10.64898/2026.10.26.757846

humanimaging

𝕏 PostBluesky